GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Sito Bio-technology Co Ltd (SZSE:300583) » Definitions » Days Sales Outstanding

Shandong Sito Bio-technology Co (SZSE:300583) Days Sales Outstanding : 101.51 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shandong Sito Bio-technology Co Days Sales Outstanding?

Shandong Sito Bio-technology Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥272 Mil. Shandong Sito Bio-technology Co's Revenue for the three months ended in Mar. 2024 was ¥244 Mil. Hence, Shandong Sito Bio-technology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 101.51.

The historical rank and industry rank for Shandong Sito Bio-technology Co's Days Sales Outstanding or its related term are showing as below:

SZSE:300583' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.52   Med: 56.55   Max: 75.7
Current: 75.7

During the past 12 years, Shandong Sito Bio-technology Co's highest Days Sales Outstanding was 75.70. The lowest was 34.52. And the median was 56.55.

SZSE:300583's Days Sales Outstanding is ranked worse than
52.78% of 881 companies
in the Biotechnology industry
Industry Median: 72.67 vs SZSE:300583: 75.70

Shandong Sito Bio-technology Co's Days Sales Outstanding increased from Mar. 2023 (60.16) to Mar. 2024 (101.51).


Shandong Sito Bio-technology Co Days Sales Outstanding Historical Data

The historical data trend for Shandong Sito Bio-technology Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sito Bio-technology Co Days Sales Outstanding Chart

Shandong Sito Bio-technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.61 57.29 44.82 54.40 66.84

Shandong Sito Bio-technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.16 68.36 78.18 60.02 101.51

Competitive Comparison of Shandong Sito Bio-technology Co's Days Sales Outstanding

For the Biotechnology subindustry, Shandong Sito Bio-technology Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Sito Bio-technology Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Sito Bio-technology Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Shandong Sito Bio-technology Co's Days Sales Outstanding falls into.



Shandong Sito Bio-technology Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Shandong Sito Bio-technology Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (196.565 + 272.117) / 2 ) / 1279.783*365
=234.341 / 1279.783*365
=66.84

Shandong Sito Bio-technology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (272.117 + 271.654) / 2 ) / 244.396*365 / 4
=271.8855 / 244.396*365 / 4
=101.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Sito Bio-technology Co  (SZSE:300583) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Shandong Sito Bio-technology Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Shandong Sito Bio-technology Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Sito Bio-technology Co (SZSE:300583) Business Description

Traded in Other Exchanges
N/A
Address
South Section of East Outer Ring Road, Dingtao County, Shandong Province, Heze, CHN, 274000
Shandong Sito Bio-technology Co Ltd is a biotechnology company. It is specialized in the research and development and production of core derivatives and derivatives of new steroid hormone drugs. The company offers bio-steroidal drug raw materials such as androstenedione, nonhydroxyandrostenedione and androstenedione.
Executives
Mi Qi Directors, executives
Wang Min Director
Kong Qing Zhi Executives
He Jian Yong Directors, executives
Ceng Qing Li Securities Affairs Representative

Shandong Sito Bio-technology Co (SZSE:300583) Headlines

No Headlines